Biomarkers of oxidative stress and personalized treatment of pulmonary tuberculosis: Emerging role of gamma-glutamyltransferase

11Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. The objectives were (i) to evaluate the impact of acute pulmonary tuberculosis (PTB) and anti-TB therapy on the relationship between AST, ALT, and GGT levels in absence of conditions related to hepatotoxicity; (ii) to evaluate the rate and the time of alterations of AST, ALT, and GGT. Design and Methods. A prospective followup of 40 adults (21 males; mean age of 34.7±5.8 years) with active PTB on initial phase and continuation phase anti-TB. Results. Only 3% (n=1) developed a transient and benign ADR at day 30 without interruption of anti-TB treatment. Within normal ranges, GGT decreased significantly from day 0 to day 60, while AST and ALT increased significantly and respectively. During day 0-day 60, there was a significant, negative, and independent association between GGT and AST. Conclusion. The initial two months led to significant improvement of oxidative stress. Values of oxidative markers in normal ranges might predict low rate of ADR. Copyright © 2012 Etienne Mokondjimobe et al.

Cite

CITATION STYLE

APA

Mokondjimobe, E., Longo-Mbenza, B., Akiana, J., Ndalla, U. O., Dossou-Yovo, R., Mboussa, J., & Parra, H. J. (2012). Biomarkers of oxidative stress and personalized treatment of pulmonary tuberculosis: Emerging role of gamma-glutamyltransferase. Advances in Pharmacological Sciences, 2012. https://doi.org/10.1155/2012/465634

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free